High times for cannabis: Epigenetic imprint and its legacy on brain and behavior

H Szutorisz, YL Hurd - Neuroscience & Biobehavioral Reviews, 2018 - Elsevier
Extensive debates continue regarding marijuana (Cannabis spp), the most commonly used
illicit substance in many countries worldwide. There has been an exponential increase of …

Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC: CBD oromucosal spray and others?

M Maccarrone, R Maldonado, M Casas… - Expert review of …, 2017 - Taylor & Francis
Introduction: The complexity of the endocannabinoid (eCB) system is becoming better
understood and new drivers of eCB signaling are emerging. Modulation of the activities of …

The synthetic cannabinoid 5F-MDMB-PICA: a case series

J Kleis, T Germerott, S Halter, V Héroux… - Forensic science …, 2020 - Elsevier
Abstract 5F-MDMB-PICA has been detected in products sold on the internet as well as in
biological samples since 2016. It is associated with serious adverse health and behavioral …

Psychosis and synthetic cannabinoids

H Deng, CD Verrico, TR Kosten, DA Nielsen - Psychiatry Research, 2018 - Elsevier
Synthetic cannabinoid (SC) products have gained popularity as abused drugs over the past
decade in many countries. The SCs broadly impact psychological state (eg, mood, suicidal …

The psychiatric consequences of cannabinoids

JP De Aquino, M Sherif, R Radhakrishnan, JD Cahill… - Clinical …, 2018 - Elsevier
With rising rates of cannabis use in the general population and an increasing number of US
states legalizing both recreational and medical cannabis use, it is important to be informed …

Cannabis use: neurobiological, behavioral, and sex/gender considerations

A Bassir Nia, C Mann, H Kaur… - Current behavioral …, 2018 - Springer
Abstract Purpose of Review To summarize the current literature on the effects of
cannabinoids in humans and to discuss the existing literature on the sex-and gender-related …

What are the psychological effects of using synthetic cannabinoids? A systematic review

H Akram, C Mokrysz, HV Curran - Journal of …, 2019 - journals.sagepub.com
Background: Synthetic cannabinoids are, typically, full agonists at the cannabinoid CB1
receptor, and therefore considerably more potent than natural cannabis and may have …

Role of the endocannabinoid system in the pathophysiology of schizophrenia: implications for pharmacological intervention

FM Leweke, JK Mueller, B Lange, S Fritze, CE Topor… - CNS drugs, 2018 - Springer
The term schizophrenia describes a group of multifaceted psychiatric conditions causing
significant impairment of the quality of life of affected patients. Although multiple …

The endocannabinoid system, aggression, and the violence of synthetic cannabinoid use, borderline personality disorder, antisocial personality disorder, and other …

NJ Kolla, A Mishra - Frontiers in behavioral neuroscience, 2018 - frontiersin.org
Endogenous and exogenous cannabinoids bind to central cannabinoid receptors to control
a multitude of behavioral functions, including aggression. The first main objective of this …

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders

MB Sami, S Bhattacharyya - Journal of Psychopharmacology, 2018 - journals.sagepub.com
A substantial body of credible evidence has accumulated that suggest that cannabis use is
an important potentially preventable risk factor for the development of psychotic illness and …